文献速递儿童青少年精神心境障碍

儿童与成人临床人群中注意缺陷多动障碍/多动性障碍患病率的系统综述与荟萃分析

Prevalence of attention deficit hyperactivity disorder/hyperkinetic disorder of pediatric and adult populations in clinical settings: a systematic review, meta-analysis and meta-regression.
PubMed 文献 · Mol Psychiatry · 2025-08-28

该系统综述与荟萃分析纳入311项研究(儿童653558例、成人43311例),评估临床环境中ADHD/HD的合并患病率。结果显示儿童患病率为32.4%(95%CI 31-34%),成人为21.4%(95%CI 20-23%),门诊高于住院,评定量表高于诊断访谈或病历回顾,且不同亚专科环境差异显著。

要点

  • 临床人群中ADHD/HD患病率儿童32.4%、成人21.4%,远高于社区估计。
  • 门诊患病率高于住院,评定量表评估高于诊断访谈或病历回顾。
  • 儿童患病率受地理区域影响,成人较大样本量关联较低患病率估计。

核心结论

  • 临床人群中ADHD/HD患病率是社区估计的8-9倍。
  • 患者面临多种不良结局风险,需重视筛查、诊断和治疗资源配置。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、CINAHL、Embase和PsycINFO从建库至2023年8月1日的英文全文文献。
  • 纳入报告儿童和成人临床人群ADHD/HD患病率的研究,共311项研究,包括653558例儿童和43311例成人参与者。
  • 采用荟萃回归评估地理区域、发表年份和样本量的影响。

主要发现

  • 儿童临床环境ADHD/HD全球合并患病率为32.4%(95%CI 31-34%)。
  • 成人临床环境ADHD/HD全球合并患病率为21.4%(95%CI 20-23%)。
  • 门诊环境患病率高于住院环境。
  • 基于评定量表的研究患病率高于诊断访谈或病历回顾的研究。
  • 儿童和成人不同亚专科环境间患病率差异显著;1981-2023年间未检测到显著时间趋势。

关键数值与推荐

  • 儿童患病率受地理区域影响,但不受发表年份或样本量影响。
  • 成人较大样本量与较低患病率估计相关。

临床怎么用

  • 临床医生应意识到临床人群中ADHD/HD患病率远高于社区,尤其在门诊和特定亚专科环境。
  • 需为筛查、诊断和治疗分配充足资源,以应对患者不良结局风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Attention-Deficit/Hyperactivity Disorder (ADHD)/Hyperkinetic Disorder (HD) is linked to increased risks of morbidity, comorbidity and mortality, with higher prevalence in clinical populations. The differential prevalence of ADHD/HD across adult and pediatric clinical populations, influenced by factors such as time trends, sex, age, geographic regions, and comorbidities, has not been systematically assessed. METHODS: MEDLINE, CINAHL, Embase and PsycINFO databases were searched from inception to 1st August 2023 for eligible full-text papers published in English, and reviewing reference lists of identified studies and review papers. Studies reporting ADHD/HD prevalence in adult and pediatric clinical populations were included. Meta-regression evaluated the effects of geographic region, year of publication and sample size. RESULTS: From 30,740 citations, we reviewed 521 full-text articles, yielding 311 studies for inclusion (including 653,558 pediatric and 43,311 adult participants). Overall, worldwide pooled prevalence of ADHD/HD in clinical settings for pediatrics was 32.4% (95% CI 31-34%), and in adults 21.4% (95% CI 20-23%). Prevalence was higher in outpatient settings than inpatient settings. Prevalence based on rating scales was higher than studies using diagnostic interviews or clinical record review. Prevalence varied significantly across subspecialist settings for children and adults. No significant time trend was detected between 1981-2023. Pediatric prevalence appears influenced by geographic region but not year of publication or sample size. For adults, larger sample sizes were associated with lower prevalence estimates. CONCLUSIONS: ADHD/HD prevalence in clinical populations is 8-9-fold higher than community estimates. With these patients at risk for many adverse outcomes, our findings underscore the critical importance of resource allocation for screening, diagnosing and treatment.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Johnson S, Lim E, Jacoby P, et al. Prevalence of attention deficit hyperactivity disorder/hyperkinetic disorder of pediatric and adult populations in clinical settings: a systematic review, meta-analysis and meta-regression. Mol Psychiatry. 2025. PMID: 40877470. doi:10.1038/s41380-025-03178-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。